EuroNanoMed I & II call statistics

EuroNanoMed I & II call statistics

During the period 2009-2014, the ERA-NET EuroNanoMed I & II has successfully launched 5 joint calls for proposals.

The first 5 calls for proposals funded 40 transnational research projects on nanomedicine involving 217 partners from 21 countries/regions participating in the calls, with about € 38 million funding from the EuroNanoMed funding agencies and a further € 28 million funding from the research partners participating in the funded projects.

Country of origin of the applicants

Altogether, 914 partners from more than 21 countries participated in these calls, in a total of 192 submitted projects. As presented in figure 1, the number of applicants per country has globally grown between 2009 and 2014, as well as the number of submitted proposals (24 and 51 respectively).

pirmas Figure 1: Number of applicants per country for the first 5 calls for proposals.

*NPC (Non participating country) refers to applicants that belonged to countries where no funding organization participated in the joint transnational call.

Overview of the 5 calls

The table below summarizes the outcomes of the first 5 calls for proposals:


Participation of research organizations in translational projects in Nanomedicine

As EuroNanoMed I & II joint calls for proposals aimed at funding translational research projects in Nanomedicine, each consortium had to include teams from at least 2 of the following categories: academia, clinic/public health, industry. The distribution between these three categories among consortia funded in the 5 calls is outlined in Figure 2. Noteworthy, 61% of the funded projects included partners from all three categories, indicating the high added value of these collaborations in nanomedicine translational research.


Figure 2: Type of research organizations funded through the five EuroNanoMed I & II joint calls for proposals.

Scientific / technological areas covered by funded projects

The first 5 calls for proposals were open to projects covering at least one of the three priority topics of the European Technology Platform Nanomedecine: Targeted delivery systems, Diagnostics, Regenerative medicine. The coverage of these three scientific areas among funded projects is presented in figure 3.


Figure 3: Distribution of scientific areas covered by funded projects in the first 5 calls for proposals.